Not applicableLooking for participantsNCT06259669
What this trial is testing
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Who this might be right for
Pregnancy RelatedAtopic Dermatitis
Incyte Corporation 958